Stella Trompet Selected Research

Pravastatin (Pravachol)

1/2022	Association of cognitive function with increased risk of cancer death and all-cause mortality: Longitudinal analysis, systematic review, and meta-analysis of prospective observational studies.
1/2020	The association of kidney function and cognitive decline in older patients at risk of cardiovascular disease: a longitudinal data analysis.
1/2019	Repeat length variations in ATXN1 and AR modify disease expression in Alzheimer's disease.
1/2018	Regression discontinuity was a valid design for dichotomous outcomes in three randomized trials.
8/2017	High-Sensitivity Cardiac Troponin Concentration and Risk of First-Ever Cardiovascular Outcomes in 154,052 Participants.
1/2017	Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients.
1/2017	Complement receptor 1 gene polymorphisms are associated with cardiovascular risk.
1/2016	High-sensitivity cardiac troponin T is associated with cognitive decline in older adults at high cardiovascular risk.
7/2014	ABCA1 gene variation and heart disease risk reduction in the elderly during pravastatin treatment.
7/2014	In search for genetic determinants of clinically meaningful differential cardiovascular event reduction by pravastatin in the PHArmacogenetic study of Statins in the Elderly at risk (PHASE)/PROSPER study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stella Trompet Research Topics

Disease

40	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 09/2008
22	Coronary Disease (Coronary Heart Disease) 01/2022 - 09/2008
13	Cognitive Dysfunction 01/2021 - 02/2008
13	Stroke (Strokes) 12/2020 - 01/2011
12	Obesity 01/2022 - 02/2015
10	Inflammation (Inflammations) 01/2021 - 03/2010
9	Heart Failure 12/2021 - 01/2016
9	Vascular Diseases (Vascular Disease) 03/2018 - 09/2008
8	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022 - 12/2011
6	Neoplasms (Cancer) 01/2022 - 12/2009
6	Atrial Fibrillation 12/2021 - 04/2014
6	Hypothyroidism 11/2021 - 01/2013
6	Myocardial Infarction 01/2021 - 02/2012
6	Type 2 Diabetes Mellitus (MODY) 01/2020 - 09/2012
5	Dementia (Dementias) 01/2021 - 02/2008
5	Atherosclerosis 01/2021 - 12/2016
4	Heart Diseases (Heart Disease) 12/2021 - 02/2012
4	Hypertension (High Blood Pressure) 01/2019 - 06/2011
4	Insulin Resistance 10/2017 - 05/2012
3	Hyperthyroidism 11/2021 - 01/2019
3	Ischemic Stroke 12/2020 - 01/2016
3	Genetic Risk Score 01/2018 - 04/2015
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2021 - 01/2020
2	Genetic Predisposition to Disease (Genetic Predisposition) 10/2016 - 04/2015
2	Thrombosis (Thrombus) 09/2013 - 03/2010
2	Coronary Restenosis 01/2013 - 01/2012
1	Esophageal Neoplasms (Esophageal Cancer) 04/2022
1	Lipodystrophy 01/2022
1	Atherosclerotic Plaque (Atheroma) 03/2021
1	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2021
1	Frailty 01/2021
1	Acute-Phase Reaction 12/2020

Drug/Important Bio-Agent (IBA)

22	Pravastatin (Pravachol)FDA LinkGeneric 01/2022 - 09/2008
18	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 01/2010
14	LipidsIBA 01/2022 - 09/2012
11	LDL CholesterolIBA 12/2021 - 09/2008
9	oxidized low density lipoproteinIBA 01/2020 - 09/2008
8	Pharmaceutical PreparationsIBA 12/2021 - 10/2011
6	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 11/2021 - 09/2013
6	Thyroxine (Levothyroxine)FDA LinkGeneric 11/2021 - 01/2013
6	Proteins (Proteins, Gene)FDA Link 07/2019 - 02/2012
5	Biological ProductsIBA 12/2021 - 01/2013
5	Triglycerides (Triacylglycerol)IBA 11/2021 - 05/2012
4	pro-brain natriuretic peptide (1-76)IBA 12/2021 - 08/2014
4	Lipoproteins (Lipoprotein)IBA 11/2021 - 12/2017
4	CholesterolIBA 01/2021 - 12/2009
4	Biomarkers (Surrogate Marker)IBA 01/2019 - 07/2010
4	C-Reactive ProteinIBA 11/2018 - 03/2010
4	HDL CholesterolIBA 01/2018 - 05/2012
3	AdiponectinIBA 12/2021 - 01/2018
3	Hormones (Hormone)IBA 01/2021 - 01/2013
3	LeptinIBA 01/2021 - 02/2016
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021 - 09/2008
3	Amino Acids FDA Link 12/2020 - 11/2018
3	HDL LipoproteinsIBA 12/2020 - 05/2012
3	Antihypertensive Agents (Antihypertensives)IBA 01/2020 - 02/2008
3	Lipoprotein(a)IBA 01/2018 - 02/2012
3	ApolipoproteinsIBA 01/2018 - 12/2009
3	Apolipoproteins E (ApoE)IBA 12/2016 - 12/2009
3	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2016 - 08/2014
2	Insulin (Novolin)FDA Link 01/2022 - 09/2012
2	TroponinIBA 12/2021 - 08/2017
2	Troponin T (Troponin T1)IBA 12/2021 - 01/2016
2	VLDL LipoproteinsIBA 11/2021 - 11/2018
2	CreatinineIBA 01/2021 - 01/2016
2	Thyroid HormonesIBA 01/2021 - 01/2019
2	Glycoproteins (Glycoprotein)IBA 01/2021 - 12/2020
2	Phenylalanine (L-Phenylalanine)FDA Link 12/2020 - 01/2018
2	Hemostatics (Antihemorrhagics)IBA 01/2019 - 03/2010
2	von Willebrand FactorIBA 01/2019 - 01/2016
2	Fibrinogen (Factor I)FDA Link 01/2019 - 09/2013
2	KetonesIBA 11/2018 - 11/2018
2	PCSK9 InhibitorsIBA 11/2018 - 11/2018
2	Cholesterol Ester Transfer ProteinsIBA 01/2018 - 01/2018
2	Genetic Markers (Genetic Marker)IBA 12/2017 - 04/2014
2	P-2 (P 2)IBA 04/2017 - 01/2016
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 01/2016
2	EnzymesIBA 01/2017 - 09/2012
1	antineoplaston A10 (A 10)IBA 01/2022
1	peroxisome-proliferator-activated receptor-gamma coactivator-1IBA 01/2022
1	ProinsulinIBA 01/2022
1	Troponin IIBA 12/2021
1	Type 4 Melanocortin Receptor (Melanocortin-4 Receptor)IBA 03/2021
1	NLR ProteinsIBA 01/2021
1	Isoleucine (L-Isoleucine)FDA Link 01/2021
1	SugarsIBA 01/2021
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2021
1	InflammasomesIBA 01/2021
1	Citric Acid (Citrate)FDA LinkGeneric 01/2021
1	HDL2 LipoproteinsIBA 12/2020
1	Pyruvic Acid (Pyruvate)IBA 12/2020
1	Histidine (L-Histidine)FDA Link 12/2020
1	DiureticsIBA 01/2020

Therapy/Procedure

14	Therapeutics 01/2021 - 01/2010
5	Percutaneous Coronary Intervention 09/2013 - 01/2011
1	Chemoradiotherapy 04/2022
1	Adjuvant Chemoradiotherapy 04/2022
1	Endarterectomy (Thromboendarterectomy) 03/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Radiotherapy 01/2021